Pfizer is latest Big Pharma to overhaul DEI goals after GSK
by
Contributor since / Followers
Contributor since / Followers
2 weeks ago
David Dee Delgado Pfizer (NYSE:PFE) has made significant updates to its diversity, equity, and inclusion
PFE
Viatris slides as FDA scrutiny on India plant clouds outlook
by
Contributor since / Followers
Contributor since / Followers
2 weeks ago
mohd izzuan Shares of Viatris (NASDAQ:VTRS) slipped ~12% in the premarket on Thursday after the
U.S. to spend up to $1B for bird flu response
by
Contributor since / Followers
Contributor since / Followers
2 weeks ago
MicroStockHub The Trump administration will allocate up to $1B to prevent the spread of bird
Pfizer taps former FDA drug chief as chief medical officer
by
Contributor since / Followers
Contributor since / Followers
3 weeks ago
Jeenah Moon/Getty Images News Pfizer (NYSE:PFE) has tapped Patrizia Cavazzoni, the former head of drug
Summit Therapeutics to test lead cancer drug with Pfizer ADCs
by
Contributor since / Followers
Contributor since / Followers
3 weeks ago
Summit Therapeutics (NASDAQ:SMMT) has entered a clinical trial collaboration to evaluate its cancer drug, ivonescimab,
First meeting of CDC vaccine advisory panel under RFK Jr. postponed
by
Contributor since / Followers
Contributor since / Followers
3 weeks ago
undefined undefined A meeting of the CDC’s Advisory Committee on Immunization Practices (ACIP), which provides
Pfizer said to be discontinuing Roche-partnered hemophilia therapy Beqvez
by
Contributor since / Followers
Contributor since / Followers
3 weeks ago
Alexandros Michailidis Pfizer (NYSE:PFE) has decided to end R&D and marketing activities related to Beqvez,
Starboard Value makes big bets in healthcare, trims tech holdings, among Q4 trades
by
Contributor since / Followers
Contributor since / Followers
4 weeks ago
Jeenah Moon/Getty Images News Jeff Smith’s Starboard Value established new holdings in health stocks Kenvue
Pharma CEOs set to meet with Trump at White House – report
by
Contributor since / Followers
Contributor since / Followers
4 weeks ago
Andrew Harnik/Getty Images News The CEOs of at least three pharmaceutical companies — Pfizer (NYSE:PFE),
Pfizer reports positive results for Talzenna/Xtandi combo
by
Contributor since / Followers
Contributor since / Followers
4 weeks ago
georgeclerk Pfizer (NYSE:PFE) reported positive results from a Phase 3 study of its drug Talzenna